Sex-specific antidepressant effects of dietary creatine with and without sub-acute fluoxetine in rats
Open accessThe DOI matches its Crossref record; 15 of the 15 references it cites were found in a registry or an index.
Abstract
The potential role of metabolic impairments in the pathophysiology of depression is motivating researchers to evaluate the treatment efficacy of creatine, a naturally occurring energetic and neuroprotective compound found in brain and muscle tissues. Growing evidence is demonstrating the benefit of oral creatine supplements for reducing depressive symptoms in humans and animals. A novel question is whether dietary creatine, when combined with antidepressant drug therapy, would be more effective than either compound alone. To answer this question, four studies were conducted to investigate the behavioral effects of combined creatine and low-dose fluoxetine treatment using the forced swim test in male and female rats. Sprague-Dawley rats were fed powdered rodent chow supplemented with 0%, 2% or 4% w/w creatine monohydrate for 5 weeks. Rats were injected with fluoxetine (5.0 or 10.0 mg/kg) or saline according to a sub-acute dosing schedule. Female rats maintained on a 4% creatine diet displayed antidepressant-like effects compared to non-supplemented females prior to fluoxetine treatment. In contrast, creatine did not alter behavior reliably in males. Following drug treatment and a second forced swim trial, the antidepressant-like profile of creatine remained significant only in females co-administered 5.0 mg/kg fluoxetine. Moreover, in females only, supplementation with 4% creatine produced a more robust antidepressant-like behavioral profile compared to either dose of fluoxetine alone. Estrous cycle data indicated that ovarian hormones influenced the antidepressant-like effects of creatine. Addressing the issue of sex differences in response to treatment may affect our understanding of creatine, its relationship with depressive behavior, and may lead to sex-specific therapeutic strategies.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Drevets, W. C., Price, J. L., & Furey, M. L. (2008) · Brain Structure and Function · doi:10.1007/s00429-008-0189-x · Cited by 2,241 · cited 1×
“…and imipramine, alter brain- and mitochondrial-type creatine kinases in the prefrontal cortex, hippocampus, and striatum (Agostinho et al., 2009; Assis et al., 2009; Santos et al., 2009), areas of the brain known to be involved with depression (Drevets et al., 2008; Maletic et al., 2007).”
Neuroprotective Effects of Creatine in a Transgenic Mouse Model of Huntington's Disease
Ferrante, R. J., Andreassen, O. A., Jenkins, B. G., Dedeoglu, A., Kuemmerle, S., Kubilus, J. K., Kaddurah-Daouk, R., Hersch, S. M., & Beal, M. F. (2000) · The Journal of Neuroscience · doi:10.1523/jneurosci.20-12-04389.2000 · Cited by 522
Direct antioxidant properties of creatine
Lawler, J. M., Barnes, W. S., Wu, G., Song, W., & Demaree, S. (2002) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.2001.6164 · Cited by 448 · cited 1×
“Second, creatine promotes antioxidant effects at the level of neural cell membranes (Lawler et al., 2002; Sestili et al., 2006, 2011).”
Enduring behavioral effects of early exposure to methylphenidate in rats
Carlezon, W. A., Mague, S. D., & Andersen, S. L. (2003) · Biological Psychiatry · doi:10.1016/j.biopsych.2003.08.020 · Cited by 248 · cited 1×
“Latency to immobility is an index of howvulnerable the individual is to the negative effects of force swim stress (Allen et al., 2010; Carlezon et al., 2003; Leussis and Andersen, 2008).”
Stöckler, S., Hanefeld, F., & Frahm, J. (1996) · The Lancet · doi:10.1016/s0140-6736(96)04116-5 · Cited by 240
Increase of total creatine in human brain after oral supplementation of creatine-monohydrate
Dechent, P., Pouwels, P. J. W., Wilken, B., Hanefeld, F., & Frahm, J. (1999) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.1999.277.3.r698 · Cited by 221
Sestili, P., Martinelli, C., Bravi, G., Piccoli, G., Curci, R., Battistelli, M., Falcieri, E., Agostini, D., Gioacchini, A. M., & Stocchi, V. (2006) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2005.10.035 · Cited by 220
Leussis, M. P., & Andersen, S. L. (2008) · Synapse · doi:10.1002/syn.20462 · Cited by 220
Kato, T., Takahashi, S., Shioiri, T., & Inubushi, T. (1992) · Journal of Affective Disorders · doi:10.1016/0165-0327(92)90099-r · Cited by 205
van der Hart, M. G. C., Czéh, B., de Biurrun, G., Michaelis, T., Watanabe, T., Natt, O., Frahm, J., & Fuchs, E. (2002) · Molecular Psychiatry · doi:10.1038/sj.mp.4001130 · Cited by 158
Research works printed but not linked: 69
- Agostinho, 2009, Effects of olanzapine, fluoxetine and olanzapine/fluoxetine on creatine kinase activity in rat brain, Brain Res Bull, 80, 337, 10.1016/j.brainresbull.2009.09.002 · DOI
- Agren, 1988, Creatinine and creatine in CSF: indices of brain energy metabolism in depression. Short note, J Neural Transm, 74, 55, 10.1007/BF01243575 · DOI · Paper page
- Allen, 2010, Chronic creatine supplementation alters depression-like behavior in rodents in a sex-dependent manner, Neuropsychopharmacology, 35, 534, 10.1038/npp.2009.160 · DOI · Paper page
- Almeida, 2006, Exocytotic release of creatine in rat brain, Synapse, 60, 118, 10.1002/syn.20280 · DOI
- Amital, 2006, Open study of creatine monohydrate in treatment-resistant posttraumatic stress disorder, J Clin Psychiatry, 67, 836, 10.4088/JCP.v67n0521c · DOI · Paper page
- Amital, 2006, Observed effects of creatine monohydrate in a patient with depression and fibromyalgia, Am J Psychiatry, 163, 1840, 10.1176/appi.ajp.163.10.1840-b · DOI
- Andres, 2008, Functions and effects of creatine in the central nervous system, Brain Res Bull, 76, 329, 10.1016/j.brainresbull.2008.02.035 · DOI · Paper page
- Andres, 2005, Effects of creatine treatment on the survival of dopaminergic neurons in cultured fetal ventral mesencephalic tissue, Neuroscience, 133, 701, 10.1016/j.neuroscience.2005.03.004 · DOI
- Arnold, 2009, Neuroprotection by estrogen in the brain: the mitochondrial compartment as presumed therapeutic target, J Neurochem, 110, 1, 10.1111/j.1471-4159.2009.06133.x · DOI · Paper page
- Assis, 2009, Effect of acute administration of ketamine and imipramine on creatine kinase activity in the brain of rats, Rev Bras Psiquiatr, 31, 247, 10.1590/S1516-44462009000300010 · DOI · Paper page
- Behl, 2002, Estrogen can protect neurons: modes of action, J Steroid Biochem Mol Biol, 83, 195, 10.1016/S0960-0760(02)00271-6 · DOI
- Blokland, 2012, The use of a test battery assessing affective behavior in rats: order effects, Behav Brain Res, 228, 16, 10.1016/j.bbr.2011.11.042 · DOI
- Búrigo, 2006, Decreased creatine kinase activity caused by electroconvulsive shock, Neurochem Res, 31, 877, 10.1007/s11064-006-9091-1 · DOI
- Cryan, 2005, Differential behavioral effects of the antidepressants reboxetine, fluoxetine, and moclobemide in a modified forced swim test following chronic treatment, Psychopharmacology (Berl), 182, 335, 10.1007/s00213-005-0093-5 · DOI · Paper page
- Cryan, 2005, Assessing substrates underlying the behavioral effects of antidepressants using the modified rat forced swimming test, Neurosci Biobehav Rev, 29, 547, 10.1016/j.neubiorev.2005.03.008 · DOI · Paper page
- Czéh, 2001, Stress-induced changes in cerebral metabolites, hippocampal volume, and cell proliferation are prevented by antidepressant treatment with tianeptine, Proc Natl Acad Sci, 98, 12796, 10.1073/pnas.211427898 · DOI · Paper page
- Dager, 2004, Brain metabolic alterations in medication-free patients with bipolar disorder, Arch Gen Psychiatry, 61, 450, 10.1001/archpsyc.61.5.450 · DOI · Paper page
- Dalla, 2009, Sex differences in learning processes of classical and operant conditioning, Physiol Behav, 97, 229, 10.1016/j.physbeh.2009.02.035 · DOI · Paper page
- Detke, 1995, Active behaviors in the rat forced swimming test differentially produced by serotonergic and noradrenergic antidepressants, Psychopharmacology (Berl), 121, 66, 10.1007/BF02245592 · DOI · Paper page
- Detke, 1997, Acute and chronic antidepressant drug treatment in the rat forced swimming test model of depression, Exp Clin Psychopharmacol, 5, 107, 10.1037/1064-1297.5.2.107 · doi:10.1037/1064-1297.5.2.107 · Paper page
- Erakovic, 2001, Altered activities of rat brain metabolic enzymes in electroconvulsive shock-induced seizures, Epilepsia, 42, 181, 10.1046/j.1528-1157.2001.30499.x · DOI · Paper page
- Fuchs, 2002, Synaptic plasticity and tianeptine: structural regulation, Eur Psychiatry, 17, 311, 10.1016/S0924-9338(02)00652-1 · DOI · Paper page
- Gabbay, 2007, Lateralized caudate metabolic abnormalities in adolescent major depressive disorder: a proton MR spectroscopy study, Am J Psychiatry, 164, 1881, 10.1176/appi.ajp.2007.06122032 · DOI
- Gledhill, 1988, Race–gender differences in serum creatine kinase activity: a study among South Africans, J Neurol Neurosurg Psychiatry, 51, 301, 10.1136/jnnp.51.2.301 · DOI · Paper page
- Hamakawa, 1999, Quantitative proton magnetic resonance spectroscopy of the bilateral frontal lobes in patients with bipolar disorder, Psychol Med, 29, 639, 10.1017/S0033291799008442 · DOI · Paper page
- Heisler, 1997, Fluoxetine decreases fat and protein intakes but not carbohydrate intake in male rats, Pharmacol Biochem Behav, 58, 767, 10.1016/S0091-3057(97)00036-1 · doi:10.1016/s0091-3057(97)00036-1
- Heisler, 1999, Reduction of fat and protein intakes but not carbohydrate intake following acute and chronic fluoxetine in female rats, Pharmacol Biochem Behav, 63, 377, 10.1016/S0091-3057(99)00021-0 · DOI
- Higuchi, 2009, Differential clinical effects of fluvoxamine by the effect of age in Japanese female major depressive patients, Neuropsychiatr Dis Treat, 5, 151
- Hroudová, 2011, Connectivity between mitochondrial functions and psychiatric disorders, Psychiatry Clin Neurosci, 65, 130, 10.1111/j.1440-1819.2010.02178.x · DOI · Paper page
- Hui, 2007, Pharmacokinetic comparisons of tail-bleeding with cannula- or retro-orbital bleeding techniques in rats using six marketed drugs, J Pharmacol Toxicol Methods, 56, 256, 10.1016/j.vascn.2007.05.006 · DOI
- Iosifescu, 2008, Brain bioenergetics and response to triiodothyronine augmentation in major depressive disorder, Biol Psychiatry, 63, 1127, 10.1016/j.biopsych.2007.11.020 · DOI · Paper page
- Ji, 2008, The Visceromotor response to colorectal distention fluctuates with the estrous cycle in rats, Neuroscience, 154, 1562, 10.1016/j.neuroscience.2008.04.070 · DOI
- Kim, 2010, Desipramine attenuates forced swim test-induced behavioral and neurochemical alterations in mice: an in vivo 1H-MRS study at 9.4T, Brain Res, 1348, 105, 10.1016/j.brainres.2010.05.097 · DOI
- Koga, 2005, Brain creatine functions to attenuate acute stress responses through GABAnergic system in chicks, Neuroscience, 132, 65, 10.1016/j.neuroscience.2005.01.004 · DOI
- Kondo, 2011, Open-label adjunctive creatine for female adolescents with SSRI-resistant major depressive disorder: a 31-phosphorus magnetic resonance spectroscopy study, J Affect Disord, 135, 354, 10.1016/j.jad.2011.07.010 · DOI · Paper page
- Kondo, 2011, Review: magnetic resonance spectroscopy studies of pediatric major depressive disorder, Depress Res Treat, 1, 10.1155/2011/650450 · DOI · Paper page
- Kornstein, 2000, Gender differences in chronic major and double depression, J Affect Disord, 60, 1, 10.1016/S0165-0327(99)00158-5 · DOI · Paper page
- Leuner, 2004, Males and females respond differently to controllability and antidepressant treatment, Biol Psychiatry, 56, 964, 10.1016/j.biopsych.2004.09.018 · DOI
- Lyoo, 2002, Magnetic resonance spectroscopy: current and future applications in psychiatric research, Biol Psychiatry, 51, 195, 10.1016/S0006-3223(01)01313-0 · DOI
- Maletic, 2007, Neurobiology of depression: an integrated view of key findings, Int J Clin Pract, 61, 2030, 10.1111/j.1742-1241.2007.01602.x · DOI · Paper page
- Malnick, 1983, Estrogen-induced creatine kinase in the reproductive system of the immature female rat, Endocrinology, 113, 1907, 10.1210/endo-113-5-1907 · DOI
- Michael, 2003, Metabolic changes within the left dorsolateral prefrontal cortex occurring with electroconvulsive therapy in patients with treatment resistant unipolar depression, Psychol Med, 33, 1277, 10.1017/S0033291703007931 · DOI · Paper page
- Michael-Titus, 2008, SONU20176289, a compound combining partial dopamine D2 receptor agonism with specific serotonin reuptake inhibitor activity, affects neuroplasticity in an animal model for depression, Eur J Pharmacol, 598, 43, 10.1016/j.ejphar.2008.09.006 · DOI
- Mirza, 2006, Increased medial thalamic creatine–phosphocreatine found by proton magnetic resonance spectroscopy in children with obsessive–compulsive disorder versus major depression and healthy controls, J Child Neurol, 21, 106, 10.1177/08830738060210020201 · DOI
- Moore, 1997, Lower levels of nucleoside triphosphate in the basal ganglia of depressed subjects: a phosphorous-31 magnetic resonance spectroscopy study, Am J Psychiatry, 154, 116, 10.1176/ajp.154.1.116 · DOI · Paper page
- Moretti, 2003, Affective disorders, antidepressant drugs and brain metabolism, Mol Psychiatry, 8, 773, 10.1038/sj.mp.4001353 · DOI
- Nery, 2009, Normal metabolite levels in the left dorsolateral prefrontal cortex of unmedicated major depressive disorder patients: a single voxel 1H spectroscopy study, Psychiatry Res, 174, 177, 10.1016/j.pscychresns.2009.05.003 · DOI
- Niklasson, 1984, Brain energy metabolism and blood–brain barrier permeability in depressive patients: analyses of creatine, creatinine, urate, and albumin in CSF and blood, Biol Psychiatry, 19, 1183
- Oliveira, 2008, The involvement of the polyamines binding sites at the NMDA receptor in creatine-induced spatial learning enhancement, Behav Brain Res, 187, 200, 10.1016/j.bbr.2007.09.004 · DOI
- Page, 1999, Serotonergic mediation of the effects of fluoxetine, but not desipramine, in the rat forced swimming test, Psychopharmacology (Berl), 147, 162, 10.1007/s002130051156 · DOI · Paper page
- Perasso, 2003, Kinetics of creatine in blood and brain after intraperitoneal injection in the rat, Brain Res, 974, 37, 10.1016/S0006-8993(03)02547-2 · DOI
- Persky, 2003, Single- and multiple-dose pharmacokinetics of oral creatine, J Clin Pharmacol, 43, 29, 10.1177/0091270002239703 · DOI · Paper page
- Prut, 2003, The open field as a paradigm to measure the effects of drugs on anxiety-like behaviors: a review, Eur J Pharmacol, 463, 3, 10.1016/S0014-2999(03)01272-X · DOI · Paper page
- Ramirez, 2002, Sexual dimorphism in rat cerebrum and cerebellum: different patterns of catalytically active creatine kinase isoenzymes during postnatal development and aging, Int J Dev Neurosci, 20, 627, 10.1016/S0736-5748(02)00102-8 · DOI
- Renshaw, 2001, Multinuclear magnetic resonance spectroscopy studies of brain purines in major depression, Am J Psychiatry, 158, 2048, 10.1176/appi.ajp.158.12.2048 · DOI · Paper page
- Rezin, 2008, Mitochondrial dysfunction and psychiatric disorders, Neurochem Res, 34, 1021, 10.1007/s11064-008-9865-8 · DOI · Paper page
- Santos, 2009, Brain creatine kinase activity is increased by chronic administration of paroxetine, Brain Res Bull, 80, 327, 10.1016/j.brainresbull.2009.09.007 · DOI
- Segal, 2007, Serum creatine kinase level in unmedicated nonpsychotic, psychotic, bipolar and schizoaffective depressed patients, Eur Neuropsychopharmacol, 17, 194, 10.1016/j.euroneuro.2006.08.010 · DOI
- Sestili, 2011, Creatine as an antioxidant, Amino Acids, 40, 1385, 10.1007/s00726-011-0875-5 · DOI · Paper page
- Sömjen, 1991, Regulation of proliferation of rat cartilage and bone by sex steroid hormones, J Steroid Biochem Mol Biol, 40, 717, 10.1016/0960-0760(91)90296-H · DOI
- Sora, 1986, Dexamethasone suppression test and noradrenergic function in affective and schizophrenic disorders, Biol Psychiatry, 21, 621, 10.1016/0006-3223(86)90123-X · DOI
- Spence, 2012, Neuroprotective effects of estrogens and androgens in CNS inflammation and neurodegeneration, Front Neuroendocrinol, 33, 105, 10.1016/j.yfrne.2011.12.001 · DOI · Paper page
- Venkatraman, 2009, Biochemical abnormalities of the medial temporal lobe and medial prefrontal cortex in late-life depression, Psychiatry Res, 172, 49, 10.1016/j.pscychresns.2008.07.001 · DOI · Paper page
- Vermeiden, 2009, Influence of gender and menopausal status on antidepressant treatment response in depressed inpatients, J Psychopharmacol (Oxf), 24, 497, 10.1177/0269881109105137 · DOI
- Volz, 1998, 31P magnetic resonance spectroscopy in the frontal lobe of major depressed patients, Eur Arch Psychiatry Clin Neurosci, 248, 289, 10.1007/s004060050052 · DOI · Paper page
- Walf, 2009, Effects of two estradiol regimens on anxiety and depressive behaviors and trophic effects in peripheral tissues in a rodent model, Gend Med, 6, 300, 10.1016/j.genm.2009.04.004 · DOI
- Wallimann, 1992, Intracellular compartmentation, structure and function of creatine kinase isoenzymes in tissues with high and fluctuating energy demands: the ‘phosphocreatine circuit’ for cellular energy homeostasis, Biochem J, 281, 21, 10.1042/bj2810021 · DOI · Paper page
- Wong, 1983, Heterogeneity of serum creatine kinase activity among racial and gender groups of the population, Am J Clin Pathol, 79, 582, 10.1093/ajcp/79.5.582 · DOI · Paper page
- Young, 2009, Sex differences in response to citalopram: a STAR∗D report, J Psychiatr Res, 43, 503, 10.1016/j.jpsychires.2008.07.002 · DOI · Paper page
Cited by
Factors influencing behavior in the forced swim test
Bogdanova, O. V., Kanekar, S., D'Anci, K. E., & Renshaw, P. F. (2013) · Physiology & Behavior · doi:10.1016/j.physbeh.2013.05.012 · Cited by 464
Self-citationSex differences in animal models of psychiatric disorders
Kokras, N., & Dalla, C. (2014) · British Journal of Pharmacology · doi:10.1111/bph.12710 · Cited by 425
Creatine for neuroprotection in neurodegenerative disease: end of story?
Bender, A., & Klopstock, T. (2016) · Amino Acids · doi:10.1007/s00726-015-2165-0 · Cited by 96
“For example, it would be of special interest, if women with PD were more likely to profit, given that rodent models of depression suggest a therapeutic Cr gender effect, favouring female animals (Allen et al. 2012).”
BackgroundDietary creatine intake and depression risk among U.S. adults
Bakian, A. V., Huber, R. S., Scholl, L., Renshaw, P. F., & Kondo, D. (2020) · Translational Psychiatry · doi:10.1038/s41398-020-0741-x · Cited by 90
Kokras, N., & Dalla, C. (2017) · Journal of Neuroscience Research · doi:10.1002/jnr.23861 · Cited by 94
“, 2009a), selective serotonin reuptake inhibitors (Allen et al., 2012; Kokras et al., 2015; Fernandez-Guasti et al., 2016), and noradrenaline reuptake inhibitors (Gunther et al.”
Background
Metadata
- Authors
- Allen, P. J., D'Anci, K. E., Kanarek, R. B., & Renshaw, P. F.
- Venue
- Pharmacology Biochemistry and Behavior
- Publisher
- Elsevier BV
- Published
- 2012-06
- Volume
- 101
- Issue
- 4
- Pages
- 588-601
- ISSN
- 0091-3057 (ISSN-L)
- OpenAlex
- W2036852450
- Cited by
- 60
- References
- 15
- FWCI
- 3.51
- Type
- journal article
- Language
- en
- Open access
- green
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Sex-specific antidepressant effects of dietary creatine with and without sub-acute fluoxetine in rats. https://app.cochat.ai/papers/10.1016/j.pbb.2012.03.005
- The paper
- Allen, P. J., D'Anci, K. E., Kanarek, R. B., & Renshaw, P. F. (2012). Sex-specific antidepressant effects of dietary creatine with and without sub-acute fluoxetine in rats. Pharmacology Biochemistry and Behavior. https://doi.org/10.1016/j.pbb.2012.03.005
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.